From #ESCCongress: The #DANCAVAS trial found that CV screening did not reduce all-cause mortality in men aged 65 to 74. “We were close, but not close enough,” said lead researcher Axel Diederichsen. tctmd.com/news/dancavas-…

From #ESCCongress, Drs Melissa Walton-Shirley and Axel Diederichsen discuss the DANCAVAS trial and the impact of screening for cardiovascular disease in men over 60 years. #CardioTwitter ms.spr.ly/6011jYAU9

Like a rookie editor that I am, I forgot to add my take of #DANCAVAS medscape.com/viewarticle/98… I really liked Andrew Foy version b/c we agree on 99% of things, but disagreed on this trial cc Axel Diederichsen #Meded

Please remember to invite me too

Steno INTEN-CT-studiet gennemføres i et samarbejde mellem de 5 Steno Diabetes Centre, kardiologiske og medicinske afdelinger i hele landet samt praktiserende læger. Steno Diabetes Center Sjælland Steno Diabetes Center Odense Steno Diabetes Center Copenhagen HealthAU OUH Odense Svendborg Aarhus Uni.hospital Diabetesforeningen Kristian Axel Diederichsen

📢 Identi. people with type II diabetes at risk of cardiovasc. dis.! 🫀🩸 Follow the STENO INTEN-CT study by PI Prof P. Løgstrup Poulsen Department of Cardiology Research AUH and Prof Axel Diederichsen Research Unit of Cardiology, OUH – collab. with K. Løkke Funck Steno Diabetes Center Aarhus   More inf. on the project will follow… ⬇️

Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS). Read more in EHJ! doi.org/10.1093/eurhea… #cardiovasculardisease #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

Quick Take: The results of the DANCAVAS trial support the concept of CV screening among appropriately selected individuals, but further studies are needed before US guidelines are changed. Read more ➡️ bit.ly/3FVO0La #AFib

Proud and grateful to know that DANCAVAS was selected as the most important paper of the year 2022 by Stephan Achenbach Likewise, acknowledged by John Mandrola, MD as 1 of the 10 best

Teaching and preparing our team for AutoPlaque analyses of the numerous CTAs in our exciting national multicenter projects #INTENCT and #DANCODE leaded by Axel Diederichsen. 🫀 Thank you Damini Dey for making this possible! Danish Cardiovascular Academy Research Unit of Cardiology, OUH

Next #twitterheartspaces cardiology panel : Cardiovascular screening with CT Calcium Scores featuring John Mandrola, MD Andrew Foy Does DANCAVAS shift the needle? nejm.org/doi/full/10.10… x.com/i/spaces/1rmxp…

David J. Cohen, MD, MSc It is a darn conundrum. Really. They force Axel Diederichsen to say screening in DANCAVAS does not reduce mortality and the CI .90-1.00. <- crazy. It’s mortality! cc Sanjay Kaul Frank Harrell

Proud to see the AVADEC trial among top 10 papers in #EHJ card.io

Does supplementation with Vit K2 really decrease progression of coronary atherosclerosis? This is tested in DANCODE (RCT: vit K2 and D vs placebo). First of 400 patients is included. Results in 2026.

Proud to know that the ESC abstract by medical student Mie Schæffer was the best Danish abstract. Looking forward to further collaboration in the future. Research Unit of Cardiology, OUH Mie Schæffer Selma Hasific

Time to celebrate✨ Inclusion of the final participant in the multicent. RCT #DANCODE In 2 years, we’ll have the results of the cardiovascular effect of high-dose vitamin K2+D3 in pts with severe coronary calcifications🫀 lnkd.in/dgdPXZCA Selma Hasific Axel Diederichsen

Vitamin K2 in future treatment of coronary atherosclerosis? We will know in two years! Thanks to a brilliant team!

The father is impressed and proud - again!

DANCAVAS 6 years follow-up, now including patient perspective Jes Lindholt Research Unit of Cardiology, OUH Dansk Cardiologisk Selskab (DCS) John Mandrola, MD Søren Zöga Diederichsen

Is DANCAVAS really the most important screening study of the last 50 years? That is the question posed by authors in a commentary in the American Journal of Preventive Cardiology: sciencedirect.com/science/articl… Matthew Budoff MD Michael J. Blaha